Document is current
Any future updates will be listed below
-
Authors
Chan, Jennifer A. https://orcid.org/0000-0003-2523-9598
Ribeiro-Oliveira, Antonio Jr.
Houchard, Aude
Dennen, Syvart
Liu, Yutong
Naga, Sai Sriteja Boppudi
Zhao, Yajin
Pommie, Christelle
Vandamme, Timon
Starr, Jason
-
Funding
Funding for this research was provided by:
Ipsen
- License Information
-
More Information
Article History
Received: 25 October 2024
Accepted: 24 January 2025
First Online: 13 March 2025
Declarations
:
: Jennifer Chan: receipt of grants/research supports: Lilly, Sanofi; receipt of honoraria or consultation fees: Novartis/Advanced Accelerator Applications, Curium, Ipsen, Lantheus; stock shareholder: Merck.. Antonio Ribeiro-Oliveira Jr.: employee: was a shareholder and an Ipsen employee at the time of manuscript development.. Aude Houchard and Christelle Pommie: shareholder and employee: Ipsen. Syvart Dennen: employee: Genesis Research Group, which received consultation fees from Ipsen. Yutong Liu: employee: Genesis Research Group, which received consultation fees from Ipsen. Sai Sriteja Boppudi Naga: employee: Genesis Research Group, which received consultation fees from Ipsen. Yajin Zhao: employee: Genesis Research Group, which received consultation fees from Ipsen. Timon Vandamme: reports consultancy, advisory roles, honoraria from AstraZeneca, Astellas, Bayer, Bristol Myers Squibb, Eisai, Elmedix, Ipsen, MyNeoTx, Nordic Pharma, Novartis, Roche, Sirtex, Servier, Takeda. Research funding (institutional) from Ipsen and Novartis. Support for travel/accomodation from Ipsen, AstraZeneca and Servier.. Jason Starr: receipt of grants/research supports (institution): Amgen, Aminex Therapeutics, Aprea Therapeutics, Arcus Biosciences, Camurus AB, Cardiff, Leap Therapeutics, Rayze Bio; receipt of honoraria or consultation: Advanced Accelerator Applications, Ipsen, Natera, Tempus Tersera; other support: travel (Camurus).
: This study was designed and implemented and reported in accordance with the Guidelines for Good Pharmacoepidemiology Practices (GPP) of the International Society for Pharmacoepidemiology (ISPE 2016) [], the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) guidelines [], and the ethical principles laid down in the Declaration of Helsinki [].
